COMBIART

This brand name is authorized in Nigeria.

Active ingredients

The drug COMBIART contains a combination of these active pharmaceutical ingredients (APIs):

`1`	Artemether UNII `C7D6T3H22J` - ARTEMETHER
	Artemether is an antimalarial agent used to treat acute uncomplicated malaria. It is administered in combination with lumefantrine for improved efficacy. This combination therapy exerts its effects against the erythrocytic stages of Plasmodium spp. and may be used to treat infections caused by P. falciparum and unidentified Plasmodium species, including infections acquired in chloroquine-resistant areas.
	Read more about Artemether
`2`	Lumefantrine UNII `F38R0JR742` - LUMEFANTRINE
	Read more about Lumefantrine

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-6700	Tablet	Combiart 20/120 Tablet TAB 20 mg; 120 mg 1 x 6's; 1 x 12's; 1 x 18's; 1 x 24's	Tablet	03/08/2021
B4-9162	Tablet	Combiart 80/480 Tablet TAB 80 mg; 480 mg 1 x 6's	Tablet	03/08/2021

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-6700, B4-9162

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.